These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 15863206)
21. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism. Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276 [TBL] [Abstract][Full Text] [Related]
22. Hemochromatosis and iron-overload screening in a racially diverse population. Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P; N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186 [TBL] [Abstract][Full Text] [Related]
23. Non-classical hereditary hemochromatosis in Portugal: novel mutations identified in iron metabolism-related genes. Mendes AI; Ferro A; Martins R; Picanço I; Gomes S; Cerqueira R; Correia M; Nunes AR; Esteves J; Fleming R; Faustino P Ann Hematol; 2009 Mar; 88(3):229-34. PubMed ID: 18762941 [TBL] [Abstract][Full Text] [Related]
25. Relation between HFE mutations and mild iron-overload expression. Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847 [TBL] [Abstract][Full Text] [Related]
26. Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload. Badar S; Busti F; Ferrarini A; Xumerle L; Bozzini P; Capelli P; Pozzi-Mucelli R; Campostrini N; De Matteis G; Marin Vargas S; Giorgetti A; Delledonne M; Olivieri O; Girelli D Am J Hematol; 2016 Jun; 91(4):420-5. PubMed ID: 26799139 [TBL] [Abstract][Full Text] [Related]
27. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C. Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851 [TBL] [Abstract][Full Text] [Related]
28. Hemochromatosis in Ireland and HFE. Ryan E; O'keane C; Crowe J Blood Cells Mol Dis; 1998 Dec; 24(4):428-32. PubMed ID: 9851896 [TBL] [Abstract][Full Text] [Related]
29. Mutation analysis of the HFE gene associated with hereditary hemochromatosis in a Venezuelan sample. Vizzi E; Loureiro CL; Gerder M; de las Nieves Garcia-Casal M; Rodríguez-Larralde A; Gerace L; Ludert JE; Liprandi F; Pujol FH Ann Hematol; 2005 Nov; 84(12):802-6. PubMed ID: 15995871 [TBL] [Abstract][Full Text] [Related]
30. Primary osteoarthritis in the ankle joint is associated with finger metacarpophalangeal osteoarthritis and the H63D mutation in the HFE gene: evidence for a hemochromatosis-like polyarticular osteoarthritis phenotype. Carroll GJ J Clin Rheumatol; 2006 Jun; 12(3):109-13. PubMed ID: 16755236 [TBL] [Abstract][Full Text] [Related]
31. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population. Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507 [TBL] [Abstract][Full Text] [Related]
32. Hereditary hemochromatosis gene (HFE) mutations C282Y, H63D and S65C in patients with idiopathic dilated cardiomyopathy. Hannuksela J; Leppilampi M; Peuhkurinen K; Kärkkäinen S; Saastamoinen E; Heliö T; Kaartinen M; Nieminen MS; Nieminen P; Parkkila S Eur J Heart Fail; 2005 Jan; 7(1):103-8. PubMed ID: 15642540 [TBL] [Abstract][Full Text] [Related]
33. Hereditary hemochromatosis gene (HFE) variants are associated with birth weight and childhood leukemia risk. Dorak MT; Mackay RK; Relton CL; Worwood M; Parker L; Hall AG Pediatr Blood Cancer; 2009 Dec; 53(7):1242-8. PubMed ID: 19711434 [TBL] [Abstract][Full Text] [Related]
34. Hereditary hemochromatosis: the clinical significance of the S65C mutation. Asberg A; Thorstensen K; Hveem K; Bjerve KS Genet Test; 2002; 6(1):59-62. PubMed ID: 12180078 [TBL] [Abstract][Full Text] [Related]
35. Hemochromatosis and severe iron overload associated with compound heterozygosity for TFR2 R455Q and two novel mutations TFR2 R396X and G792R. Lee PL; Barton JC Acta Haematol; 2006; 115(1-2):102-5. PubMed ID: 16424658 [TBL] [Abstract][Full Text] [Related]
36. Prevalence and clinical significance of HFE gene mutations in patients with iron overload. Brandhagen DJ; Fairbanks VF; Baldus WP; Smith CI; Kruckeberg KE; Schaid DJ; Thibodeau SN Am J Gastroenterol; 2000 Oct; 95(10):2910-4. PubMed ID: 11051367 [TBL] [Abstract][Full Text] [Related]
37. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases. Barton JC; Lee PL; West C; Bottomley SS Am J Hematol; 2006 Oct; 81(10):760-7. PubMed ID: 16838333 [TBL] [Abstract][Full Text] [Related]
38. Analysis of the HFE gene (C282Y, H63D and S65C) mutations in a general Chinese Han population. Lin A; Yan WH; Xu HH; Zhu M; Zhou MY Tissue Antigens; 2007 Sep; 70(3):252-5. PubMed ID: 17661915 [TBL] [Abstract][Full Text] [Related]
39. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload. Vercesi E; Cerani P; Rolandi V; Rovati A; Bergamaschi G Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923 [TBL] [Abstract][Full Text] [Related]
40. Association of porphyria cutanea tarda with hereditary hemochromatosis. Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]